Allergan, Inc.: FDA filings under this applicant name
FDA lists 38 510(k) clearances under 2 spellings of the applicant name “Allergan, Inc.” (first 1982, latest 2021), plus 8 PMA and 1 De Novo decisions, across 20 product codes in 5 review panels. Median 510(k) review time under this name: 75 days. Since 2017 the median was 212 days, against 166 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 1 | 203 |
| 2014 | 0 | — |
| 2015 | 1 | 269 |
| 2016 | 1 | 179 |
| 2017 | 0 | — |
| 2018 | 2 | 148 |
| 2019 | 1 | 146 |
| 2020 | 1 | 252 |
| 2021 | 1 | 212 |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Allergan, Inc. took a median 212 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 166 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LPN | Accessories, Soft Lens Products | 12 | 12 |
| HPX | Lens, Contact (Polymethylmethacrylate) | 8 | 8 |
| HQC | Unit, Phacofragmentation | 3 | 3 |
| LCJ | Tissue Expander And Accessories | 3 | 3 |
| LMH | Implant, Dermal, For Aesthetic Use | 3 | 0 |
| FTR | Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled | 2 | 0 |
| HNO | Keratome, Ac-Powered | 2 | 2 |
| QBR | Intranasal Electrostimulation Device For Dry Eye Symptoms | 2 | 1 |
| EIB | Syringe, Irrigating (Dental) | 1 | 1 |
| FWM | Prosthesis, Breast, Inflatable, Internal, Saline | 1 | 0 |
Plus 10 more product codes.
Review panels
- Ophthalmic (31)
- General and Plastic Surgery (12)
- Gastroenterology and Urology (2)
- Dental (1)
- Neurology (1)
Most recent Allergan, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K203229 | NATRELLE INSPIRA Single Use Sizers for Gel Implants | MRD | 2021-06-02 | 212 |
| K193589 | TrueTear Intranasal Tear Neurostimulator | QBR | 2020-08-31 | 252 |
| K190674 | REFRESH RELIEVA For CONTACTS | LPN | 2019-08-08 | 146 |
| K180826 | Natrelle 133 Plus MICROCELL Tissue Expander | LCJ | 2018-12-21 | 266 |
| K182054 | Natrelle 133S Tissue Expander | LCJ | 2018-08-29 | 29 |
| K161457 | XEN Glaucoma Treatment System | KYF | 2016-11-21 | 179 |
| K143354 | Natrelle 133 Plus Tissue Expander | LCJ | 2015-08-20 | 269 |
| K123128 | SERI SURGICAL SCAFFOLD | OXF | 2013-04-25 | 203 |
| K083812 | REFRESH OPTIVE LENS COMFORT REWETTING DROPS | LPN | 2009-07-09 | 199 |
| K051852 | SINGLE AMPLIFIER FOR BOTOX | GWL | 2005-09-14 | 68 |
28 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN170086 | De Novo | Intranasal Electrostimulation Device For Dry Eye Symptoms | 2018-05-17 |
| P110033 | PMA | JUVEDERM VOLUMA XC | 2013-10-22 |
| P040046 | PMA | NATRELLE HIGHLY COHESIVE SILICONE-FILLED BREAST IMPLANTS | 2013-02-20 |
| P020056 | PMA | NATRELLE SILICONE-FILLED BREAST IMPLANTS | 2006-11-17 |
| P050047 | PMA | JUVEDERM 24HV, JUVEDERM 30 AND JUVEDERM 30HV GEL IMPLANTS | 2006-06-02 |
Recalls
5 product recalls in 4 recall events; 0 initiated in the last five years. Most recent: 2015-06-18.
17 product recalls in 9 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Allergan PLC (10), Inamed Corp (3), Advanced Medical Optics, Inc. (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Allergan, Inc. is the lead sponsor of 67 device studies on ClinicalTrials.gov (1 active or recruiting). Most recent:
- NCT04609020: Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment (Completed, started 2023-02-15)
- NCT05452070: A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants (Completed, started 2022-09-02)
- NCT05088980: Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants (Completed, started 2021-10-19)
- NCT05119777: HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation (Completed, started 2021-10-13)
- NCT05077488: VFORM: Prospective, Open Label, Study to Evaluate VOLIFT With Lidocaine Treatment for FORehead Contouring and Marionette Lines (Completed, started 2021-09-15)
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Allergan, Inc. (a text match, not an official crosswalk):
- L8616 — Microphone for use with cochlear implant device, replacement (via LMH)
- L8615 — Headset/headpiece for use with cochlear implant device, replacement (via LMH)
- L8617 — Transmitting coil for use with cochlear implant device, replacement (via LMH)
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Allergan, Inc. (35)
- Allergan (12)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Allergan Medical Optics (7 510(k)s)
- Allergan Humphrey (3 510(k)s)
- Allergan Optical (2 510(k)s)
- Allergan Medical (1 510(k)s)
- Allergan Pharmaceuticals, Inc. (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Allergan, Inc.?
FDA lists 38 510(k) clearances under 2 spellings of the applicant name “Allergan, Inc.” (first 1982, latest 2021), plus 8 PMA and 1 De Novo decisions, across 20 product codes in 5 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Allergan, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Allergan, Inc. is 75 days. Since 2017: 212 days, versus 166 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Allergan, Inc.?
The most frequent FDA product codes under this applicant name are LPN (Accessories, Soft Lens Products, 12); HPX (Lens, Contact (Polymethylmethacrylate), 8); HQC (Unit, Phacofragmentation, 3).
Next steps
- See all 38 Allergan, Inc. clearances with predicates and recalls
- Run predicate analysis for product code LPN, Allergan, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.